Indazole derivatives as JNK inhibitors

Details for Australian Patent Application No. 2004232981 (hide)

Owner Signal Pharmaceuticals, LLC.

Inventors Chao, Qi; Buhr, Chris A.; Satoh, Yoshitaka; Sahasrabudhe, Kiran; Sakata, Steven T.; Albers, Ronald; Plantevin, Veronique; Bhagwat, Shripad S.; Sapienza, John; Ferri, Rachel

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2004232981

PCT Pub. Number WO2004/094388

Priority 10/414,839 16.04.03 US

Filing date 16 April 2004

Wipo publication date 4 November 2004

International Classifications

C07D 231/56 Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

C07D 401/12 Heterocyclic compounds containing two or more hetero rings

A61K 031/416 - condensed with carbocyclic ring systems, e.g. indazole

C07D 403/04 Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 401/14 Heterocyclic compounds containing two or more hetero rings

C07D 409/14 Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 401/04 Heterocyclic compounds containing two or more hetero rings

C07D 405/14 Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 403/14 Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/12 Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 409/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 405/04 Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

A61P 019/00 Drugs for skeletal disorders

C07D 413/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 403/12 Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

1 December 2005 PCT application entered the National Phase

  PCT publication WO2004/094388 Priority application(s): WO2004/094388

11 November 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004232982-Method and apparatus for generating high purity eluant

2004232976-Immuno-amplification